BIODESIX INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $88.5 | $71.3 | $49.1 | $38.2 | $54.5 |
| Operating income | -$27.9 | -$34.5 | -$41.3 | -$50.6 | -$40.9 |
| Net income | -$35.3 | -$42.9 | -$52.1 | -$65.4 | -$43.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$23.5 | -$51.9 | -$45.8 | -$48.3 | -$30.5 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Shares outstanding 10.1M · Free float 52.8%
Annual filing data through FY ended December 31, 2025; float as of August 29, 2026.